Carmustine bulk supplier for pharma manufacturers

Carmustine 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg

Reference Brands: BiCNU (USA)

Carmustine 100 mg lyophilised powder with ethanol diluent for intravenous infusion, a nitrosourea cytotoxic. For oncology importers, distributors, hospital pharmacies and transplant centres.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Carmustine? List it or send an offer →

Product Description:

Carmustine, also called BCNU, is a nitrosourea alkylating agent. It cross-links DNA and RNA, stopping cancer cells copying their genetic material. Being highly lipid-soluble, it crosses the blood-brain barrier, which explains its long place in brain tumour regimens. This page covers the 100 mg vial for intravenous use: a lyophilised powder with a separate vial of sterile ethanol diluent, prepared by hospital oncology and transplant pharmacies. An implantable wafer form used during brain surgery is a different product.

Intravenous carmustine is used for primary and metastatic brain tumours, multiple myeloma with prednisone, and relapsed Hodgkin and non-Hodgkin lymphoma. It is also part of high-dose conditioning before autologous stem cell transplant, often in the BEAM regimen. Marrow suppression is delayed, with lowest counts four to six weeks after a dose, so courses are at least six weeks apart. Pulmonary toxicity is dose-related and can appear years later, so lung function is tested. Infusion runs over at least two hours to avoid flushing and site pain.

Sourcing notes. Carmustine is a prescription-only cytotoxic, handled under cytotoxic precautions. Unopened vials need a 2-8 °C cold chain throughout. The drug melts just above 30 °C, and heat-exposed vials showing an oily film must be discarded, so shipment temperature logs matter. Diluted infusions go in glass or polypropylene containers, protected from light. Ask for a CoA per batch with impurity profile, sterility data, the GMP certificate for sterile cytotoxic manufacture, a CoPP and a CTD or ACTD dossier. Confirm the diluent vial is included and the shelf life left at delivery.

Carmustine — third party manufacturing & bulk supply

Carmustine 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Carmustine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Carmustine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Carmustine →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Carmustine is listed as Injection in 100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Carmustine is referenced against BiCNU (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.